Delivery Order SPE2DB22D3016-SPE2DB25FASZ2
Award Date
4/2/25
Potential Completion Date
4/3/25
Potential Value
$1.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,679.50, is a delivery order for the supply of 4,567,055,954 units of the medication Vyvanse 50 mg capsules. The contract has an ultimate completion date of January 28, 2025 and is a firm fixed-price contract. This award is part of a larger Indefinite Delivery Contract (IDC) that...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,501.86, is for the delivery of Vyvanse 50 mg capsules (100 count) to support military and federal healthcare programs. The contract has an ultimate completion date of January 2, 2025 and is a firm fixed-price delivery order. This contract award is part of a larger Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,783.60 firm-fixed-price delivery order is for 4,567,860,309 units of the prescription medication Vyvanse 50 mg capsules. The contract has an ultimate completion date of April 10, 2025 and was awarded on April 9, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,359,320 units of Vyvanse 50 mg capsules. The contract has a ceiling value of $4,006.50 and is a firm-fixed price delivery order, with a period of performance through November 7, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,085.15, is a Firm Fixed Price delivery order for the supply of 4,567,557,992 units of the prescription drug Vyvanse 30 mg capsules. The contract has an ultimate completion date of March 13, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract...
This federal contract award, valued at $13,325.21, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for the supply of 4,565,146,355 units of Vyvanse 50 mg capsules. The contract has a firm fixed price and an ultimate completion date of July 16, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The specific award is for $5,194.82 to provide 4,563,087,245 units of the pharmaceutical product Vyvanse 20 mg capsules. This delivery order has a...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,006.66, is a delivery order for the supply of 4,567,264,038 units of the prescription drug Vyvanse 30 mg capsules. The contract has an ultimate completion date of February 14, 2025 and uses a firm fixed price pricing type. This award is part of a larger Indefinite Delivery Contract (IDC) that...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,117.04, is a delivery order for 4,567,009,775 units of the prescription medication Vyvanse 50 mg capsule. The contract has an ultimate completion date of January 23, 2025 and is a firm fixed-price arrangement. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The $5,764.08 firm fixed-price delivery order contract is for the supply of 4,568,337,212 units of the 40 mg capsule form of the prescription medication Vyvanse. The contract has an ultimate completion date of May 23, 2025 and was awarded on May 22, 2025. This award is not a set-aside and appears to be part...